High Prevalence of the MLH1 V384D Germline Mutation in Patients With HER2-positive Luminal B Breast Cancer

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47439-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Modulating Cancer Stemness Provides Luminal a Breast Cancer Cells With HER2 Positive-Like Features

Journal of Cancer
Oncology
2020English

A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations

Journal of Medical Genetics
Genetics
2010English

Locoregional Therapy in Luminal-Like and HER2-enriched Patients With De Novo Stage IV Breast Cancer

SpringerPlus
Multidisciplinary
2013English

An Intronic Mutation in MLH1 Associated With Familial Colon and Breast Cancer

Familial Cancer
Cancer ResearchOncologyGenetics
2010English

Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-Her2 Treatments

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2020English

Risk Factors for the Development of Brain Metastases in Patients With HER2-positive Breast Cancer

ESMO Open
Cancer ResearchOncology
2018English

Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?

Oncology in Clinical Practice
Oncology
2019English

Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry

Cancers
Cancer ResearchOncology
2018English

Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer

Oncotarget
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy